ASX - By Stock
|
CYP |
Re:
Ann: Notification regarding unquoted securities - CYP
|
|
JB1975
|
4 |
932 |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
4
|
932
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Notification regarding unquoted securities - CYP
|
|
JB1975
|
4 |
932 |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
4
|
932
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
551
|
198K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
551
|
198K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
551
|
198K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
551
|
198K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
551
|
198K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
551
|
198K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
0 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
551
|
198K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
1 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
551
|
198K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
5 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
551
|
198K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
JB1975
|
272 |
113K |
1 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
272
|
113K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
198K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
198K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
198K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
198K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
198K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
198K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
198K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
198K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
551 |
198K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
198K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
JB1975
|
2.1K |
676K |
11 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
2.1K
|
676K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
61 |
10K |
3 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
61
|
10K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
61 |
10K |
1 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
61
|
10K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
61 |
10K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
10K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
61 |
10K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
10K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
61 |
10K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
10K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
61 |
10K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
10K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
61 |
10K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
61
|
10K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
61 |
10K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
61
|
10K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
3.0K |
1 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
19
|
3.0K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
3.0K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
19
|
3.0K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
JB1975
|
154 |
46K |
6 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
46K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
3.0K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
19
|
3.0K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
3.0K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
19
|
3.0K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
3.0K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
19
|
3.0K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
3.0K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
19
|
3.0K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
3.0K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
19
|
3.0K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.5K |
2.8M |
4 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.5K |
2.8M |
5 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.5K |
2.8M |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.5K |
2.8M |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.5K |
2.8M |
8 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
JB1975
|
362 |
117K |
2 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
362
|
117K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
JB1975
|
362 |
117K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
362
|
117K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
JB1975
|
362 |
117K |
5 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
362
|
117K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
JB1975
|
362 |
117K |
2 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
362
|
117K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.5K |
2.8M |
5 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.5K |
2.8M |
6 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.5K |
2.8M |
2 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
2
|
|